在HNSCCs潜在的microRNA预后签名:一个系统的审查
Mario Dioguardi1, Francesca Spirito1, Giovanna Iacovelli1
1Department of Clinical and Experimental Medicine, University of Foggia, Via Rovelli 50, 71122 Foggia, Italy.
Non-coding RNA
|September 22, 2023
概括
这项研究研究了microRNAs (miRNAs) 作为头部和部状细胞癌 (HNSCCs) 的潜在生物标志物. 虽然特定的miRNAs显示出希望,但需要进一步的研究来确认它们在HNSCC预后中的临床实用性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物标志物 生物标志物
背景情况:
- 头部和部状细胞癌 (HNSCCs) 具有显著的死亡率和发病率,通常在晚期被诊断出来.
- 微RNAs (miRNAs) 参与HNSCC的发展和进展,作为瘤基因或瘤抑制剂.
- 患者样本中的独特miRNA模式为HNSCC诊断,预后和治疗向提供了潜力.
研究的目的:
- 确定对HNSCC.中的有前途的miRNA进行系统审查和临床试验.
- 使用顶部miRNAs创建分子签名,以评估来自癌症基因组图谱 (TCGA) 的HNSCC队列中的预后价值.
主要方法:
- 在PubMed,Scopus,Science Direct和Cochrane图书馆搜索了"签名microRNA"和"HNSCC"等关键词.
- 包括15个系统文献评论和76个预后临床报告.
- 根据患者数量选择了三种高度研究的miRNAs (miR-21,miR-155,miR-375) 来进行基于患者数量的分子生物签名.
主要成果:
- 在比较高和低的组织表达水平时,miR-21,miR-155和miR-375的分子生物签名显示总生存 (OS) 的危险比 (HR) 为1.28 (95% CI: [0.95,1.72]).
- 这表明这些miRNA在HNSCC中的潜在预后作用.
结论:
- 目前的证据表明,miRNAs对HNSCC查和临床管理具有潜在的预后价值.
- 建议进行大规模的队列研究,以验证这些miRNA单独或组合的临床实用性,用于HNSCC的随访和治疗.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K


